Primrose Bio

Three weeks to go!?Join us as we explore the critical role of RNA polymerase selection in optimizing IVT for high-quality, streamlined and cost-effective mRNA manufacturing. Not all polymerases perform equally across different template sizes, designs, and mRNA formats. This webinar will present key insights and case study data on a panel of?custom Prima RNApols?—engineered to enhance IVT efficiency and outperform conventional T7 RNA polymerase in?overall mRNA quality, yield, and purity. Register now: https://lnkd.in/gKjYJSPZ #PrimaRNApols #mRNA #webinar

We are looking forward to Bio-Europe in Italy, March 17-19. Connect with Alec Tzianabos to learn more about our scalable, efficient and cost-effective manufacturing solutions for complex drug manufacturing and design challenges. Reach out via [email protected], LinkedIN or via the BIO Partnering One-on-One platform. #mRNA #proteinexpression #crm197

Primrose Bio's polymerase surpasses T7, producing high-quality, long-template mRNA with ultra-low dsRNA while requiring less DNA template.?Sign up to be notified of our Prima RNApols? Extend launch: https://lnkd.in/ggKTcsfB #mRNA #PrimaRNApols #vaccines #therapeutics

#Webinar - Achieving High-Quality, Efficient #mRNA Synthesis for Streamlined and Cost-Effective Manufacturing Next month, Primrose's CEO Helge Zieler, PhD, and advisor, Khaled Yamout, will present insights and case study data on our panel of custom Prima RNApols? engineered to enhance IVT efficiency and outperform conventional T7 RNA polymerase in mRNA quality, yield, and purity. ???Date: Thursday, March 27th, 2025 ??Time: 09:00 PDT / 12:00 EDT / 16:00 GMT / 17:00 CET Learn more and register here: https://lnkd.in/gSH75ntH

Overcome mRNA manufacturability challenges with custom enzymes that boost quality and yield, while reducing impurities and costs. Primrose Bio has developed a panel of over 20 different RNA polymerases. We screen this panel to identify enzymes that deliver high IVT performance using your materials and to the desired KPIs. Learn more about our evaluation program to identify an RNApol suited for your product and process: https://bit.ly/3E9C75Y #mRNA #PrimaRNApols #vaccines #therapeutics

Primrose Bio and Serum Institute of India Pvt. Ltd. collaborate to develop a novel multi-antigen vaccine for infections that affect millions of people globally. Both companies will contribute towards the design of the vaccine with Primrose fully responsible for developing manufacturing strains using its Pfenex Expression Technology and SIIPL responsible for further development and commercialization. Read the full announcement to learn more: https://lnkd.in/gQM-D9t3 #Vaccines #GlobalHealth

Primrose Bio is attending JPM Week! Join us for JPM 2025 in San Francisco, January 13–16, to meet with Helge Zieler, CEO; Simon Latimer, CFO; Michele Rubino, CBO; and Louis J. Cantolupo, VP of Business Development. Use BIO's One-on-One Partnering to set up meetings with our team or reach us via [email protected]. We are looking forward to great discussions and opportunities for collaboration to solve complex drug manufacturing and design challenges. #JPMWeek2025 #PrimroseBio #Therapeutics #Innovation

Join us at PEGS Europe on Nov 6 at 10AM to hear Diane Retallack, PhD's talk entitled "Streamlined Antibody and Therapeutic Development Using the Pfenex Expression Technology? Platform." Discover how our pioneering platform with a legacy of success and value creation is transforming the field! Learn more: https://bit.ly/4ftdr5E #PEGSEurope #PrimroseBio #PfenexExpressionTechnology

We're stirring up a potion of innovation every day to conjure boo-tiful results. Wishing you a Happy Halloween! ????

Meet with Primrose Bio and Intravacc at The World Vaccine Congress-EU in Barcelona next week! Together, we aim to revolutionize the landscape of conjugate vaccine development, ultimately benefiting millions worldwide. #Pelicrm197 #Intravacc #vaccines #crm197